COOPER, D.; MOISAN, J.; ABDOUS, B.; GRÉGOIRE, J.-P. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 15, n. 3, 2018. Disponível em: https://jptcp.com/index.php/jptcp/article/view/229. Acesso em: 16 jul. 2024.